Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

ANVS

Annovis Bio (ANVS)

Annovis Bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:ANVS
DatumZeitQuelleÜberschriftSymbolFirma
11/12/202422h25Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
09/12/202422h15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
05/12/202414h30GlobeNewswire Inc.Annovis CEO Showcases Groundbreaking Advances in Neurodegenerative Disease Treatment on Today’s MarketplaceNYSE:ANVSAnnovis Bio Inc
12/11/202412h02Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
08/11/202423h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
31/10/202413h00GlobeNewswire Inc.IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis BioNYSE:ANVSAnnovis Bio Inc
15/10/202414h12Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
03/10/202414h45InvestorsHub NewsWireBeyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and MoreNYSE:ANVSAnnovis Bio Inc
02/10/202415h00InvestorsHub NewsWireTransforming Alzheimer's Treatment: Innovative Combinations to Boost CognitionNYSE:ANVSAnnovis Bio Inc
30/09/202414h38Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
15/08/202413h15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
14/08/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
06/08/202414h09Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
05/08/202414h00GlobeNewswire Inc.IBN Announces Latest Episode of The Bell2Bell Podcast Featuring Annovis Bio CEO Dr. Maria Maccecchini, Live from AAIC 2024NYSE:ANVSAnnovis Bio Inc
16/07/202414h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
10/07/202422h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
08/07/202412h37IH Market NewsParamount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More NewsNYSE:ANVSAnnovis Bio Inc
13/06/202412h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
11/06/202423h00Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
05/06/202422h32Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
21/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
21/05/202413h30GlobeNewswire Inc.Annovis Announces New Publication in a Peer-Reviewed JournalNYSE:ANVSAnnovis Bio Inc
13/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
13/05/202413h30GlobeNewswire Inc.Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial ResultsNYSE:ANVSAnnovis Bio Inc
10/05/202423h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ANVSAnnovis Bio Inc
09/05/202422h03Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
09/05/202413h30GlobeNewswire Inc.Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s DiseaseNYSE:ANVSAnnovis Bio Inc
06/05/202423h12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:ANVSAnnovis Bio Inc
06/05/202423h11Edgar (US Regulatory)Form 8-K - Current reportNYSE:ANVSAnnovis Bio Inc
06/05/202413h30GlobeNewswire Inc.Annovis Bio CEO Maria Maccecchini Issues Letter to StockholdersNYSE:ANVSAnnovis Bio Inc
 Showing the most relevant articles for your search:NYSE:ANVS

Kürzlich von Ihnen besucht

Delayed Upgrade Clock